Inhaled pirfenidone solution (AP01) for IPF: a randomised, open-label, dose-response trial.
West A, Chaudhuri N, Barczyk A, Wilsher ML, Hopkins P, Glaspole I, Corte TJ, Šterclová M, Veale A, Jassem E, Wijsenbeek MS, Grainge C, Piotrowski W, Raghu G, Shaffer ML, Nair D, Freeman L, Otto K, Montgomery AB.
West A, et al.
Thorax. 2023 Sep;78(9):882-889. doi: 10.1136/thorax-2022-219391. Epub 2023 Mar 22.
Thorax. 2023.
PMID: 36948586
Free article.
Clinical Trial.